Zhengxin Xu

Zhengxin Xu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LGLi-Yuan Gu
Li-Yuan Gu
YSYun Sun
Yun Sun
HTHai-Tao Tang
Hai-Tao Tang
ZXZhengxin Xu
Zhengxin Xu

18 October 2019 in Oncology Letters
Verified
Journal Article
Open access
PDF file
HMHongxin Ma
Hongxin Ma
LZLei Zhu
Lei Zhu
JRJingna Ren
Jingna Ren
BRBenlong Rao
Benlong Rao
MSMaomao Sha
Maomao Sha
ZXZhengxin Xu
Zhengxin Xu
The recurrence and metastasis of hepatocellular carcinoma (HCC) are a major concern in current research. Epithelial-mesenchymal transition (EMT) is the leading cause underlying the high mobility and invasiveness of tumor cells. Myricetin is a natural flavonol with various pharmacological activities. The effects of myricetin on the migration and invasion of HCC MHCC97H cells were evaluated in the present study. Wound healing, Transwell migration and invasion assays were used to examine cell migration and invasion. Western blot analysis and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) were used to examine the expression of epithelial (E)-cadherin, neural (N)-cadherin and vimentin. The present study aimed to investigate the effects of myricetin on the migration and invasion of HCC MHCC97H cells. It was indicated that myricetin decreased the viability of MHCC97H cells in a concentration and time-dependent manner, and inhibited MHCC97H cells migration and invasion. As the concentration of myricetin increased, filopodia and lamellipodia in cells weakened and cells were arranged more closely. RT-qPCR and western blotting revealed that myricetin upregulated E-cadherin expression and downregulated N-cadherin. Collectively, the results of the present study demonstrate that myricetin may inhibit the migration and invasion of HCC MHCC97H cells by inhibiting the EMT process.

22 September 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
JDJinfang Deng
Jinfang Deng
ZHZhenpeng He
Zhenpeng He
XLXiuru Li
Xiuru Li
WCWei Chen
Wei Chen
ZYZiwen Yu
Ziwen Yu
LFLei Fang
Lei Fang
Background. Huangkui capsule (HKC) comprises the total flavonoid extract of flowers of Abelmoschus manihot (L.) Medicus. This study aimed to explore the effects of HKC on lipopolysaccharide- (LPS-) induced acute lung injury (ALI) in mice and LPS-stimulated RAW 264.7 cells. Methods. Enzyme-linked immunosorbent assay, histopathology, spectrophotometry, and quantitative real-time polymerase chain reaction were used for the assessments. Statistical analysis was performed using a one-way analysis of variance. Results. LPS significantly increased lung inflammation, neutrophil infiltration, and oxidative stress and downregulated lung miR-451 expression. Treatment with HKC dramatically, reduced the total cell count in the bronchoalveolar lavage fluid (BALF), and inhibited myeloperoxidase activity in the lung tissues 24h after LPS challenge. Histopathological analysis demonstrated that HKC attenuated LPS-induced tissue oedema and neutrophil infiltration in the lung tissues. Additionally, the concentrations of tumour necrosis factor- (TNF-) α and interleukin- (IL-) 6 in BALF and IL-6 in the plasma reduced after HKC administration. Moreover, HKC could enhance glutathione peroxidase and catalase activities and upregulate the expression of miR-451 in the lung tissues. In vitro experiments revealed that HKC inhibited the production of nitric oxide, TNF-α, and IL-6 in LPS-induced RAW 264.7 cells and mouse primary peritoneal macrophages. Additionally, HKC downregulated LPS-induced transcription of TNF-α and IL-6 in RAW 264.7 cells. Conclusions. These findings suggest that HKC has anti-inflammatory and antioxidative effects that may protect mice against LPS-induced ALI and macrophage activation.

10 January 2020 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
YDYa‐Ya Du
Ya‐Ya Du
LZLi Zou
Li Zou
XWXiu‐Xiu Wang
Xiu‐Xiu Wang
LDLe‐Yao Dai
Le‐Yao Dai
XLXin‐Nan Ling
Xin‐Nan Ling
ZXZhengxin Xu
Zhengxin Xu

19 March 2021 in Naunyn-Schmiedeberg's Archives of Pharmacology
Verified
Journal Article
Closed access
PDF file
MLMeng-Ting Li
Meng-Ting Li
YDYa-Ya Du
Ya-Ya Du
FZFei Zhong
Fei Zhong
JWJie-Ru Wang
Jie-Ru Wang
YGYou-Wei Gu
You-Wei Gu
ZXZhengxin Xu
Zhengxin Xu

22 August 2024 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
XLXiao Liu
Xiao Liu
JXJie Xiang
Jie Xiang
SFShuyuan Fan
Shuyuan Fan
XCXumin Chen
Xumin Chen
CPChengzhan Peng
Chengzhan Peng
ZXZhengxin Xu
Zhengxin Xu